Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-42,066
Closed -$2.07M 179
2018
Q2
$2.07M Sell
42,066
-574
-1% -$32.6K 0.27% 36
2018
Q1
$2.55M Sell
42,640
-1,835
-4% -$122K 0.33% 35
2017
Q4
$3.5M Sell
44,475
-384
-0.9% -$31K 0.43% 32
2017
Q3
$3.77M Buy
44,859
+19,548
+77% +$1.39M 0.45% 32
2017
Q2
$1.66M Sell
25,311
-2,302
-8% -$157K 0.21% 41
2017
Q1
$2.01M Sell
27,613
-307
-1% -$20.2K 0.25% 36
2016
Q4
$1.64M Buy
+27,920
New +$1.47M 0.21% 40

Other funds holding ADNT

Cannell & Spears's ADNT Position: Q3 2018 in Review

Cannell & Spears sold out of Adient (ADNT) in Q3 2018, closing a stake of 42,066 shares — an estimated $2.07M sold.

Cannell & Spears first reported a position in ADNT in Q4 2016 and held it in 7 quarters. The position peaked at $3.77M in Q3 2017. 401 funds tracked by Wall St. Rank hold ADNT as of Q3 2018.

  • Cannell & Spears reported no remaining Adient position as of Q3 2018 after selling out during the quarter.
  • Cannell & Spears sold 42,066 Adient shares in Q3 2018, an estimated $2.07M.
  • Cannell & Spears first reported a position in Adient in Q4 2016 and held it in 7 quarters.
  • Cannell & Spears's Adient position peaked at $3.77M in Q3 2017.
  • 401 funds tracked by Wall St. Rank held Adient as of Q3 2018.

Based on Cannell & Spears's 13F filing for Q3 2018, filed 13 Nov 2018.